Teleflex didn’t disclose a price tag in the acquisition of the private late-stage surgical device maker. Limerick, Pa.-based Teleflex said it acquired Eon in hopes of breaking into the relatively untouched microlaparoscopy and needlescopic technologies market and "remove barriers to broad market adoption," according to a statement
Eon Medical, founded in 2009 in Israel, calls its microlaparoscopy devices an alternative to natural-orifice or single-incision surgery, providing scarless incisions without significantly changing the approach of laparoscopic surgery.
"This acquisition is consistent with our focus on innovative technologies and will greatly expand Teleflex’s offerings that address the significant market opportunity for minimally invasive laparoscopic procedures," Benson Smith, CEO of Teleflex said in the statement.
Teleflex also announced CE Mark clearance in Europe for its Arrow GPSCath Balloon Catheter, a dual-function catheter that allows multiple vascular procedures to be performed at once.
"The Arrow GPSCath Balloon Dilatation Catheter with VisioValve Technology is setting a higher bar for peripheral and dialysis access angioplasty performance," said CEO Benson Smith in a company statement.